{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T18:54:09Z","timestamp":1782327249599,"version":"3.54.5"},"reference-count":75,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T00:00:00Z","timestamp":1752192000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Immune-mediated kidney diseases involve the immune system attacking the kidneys, resulting in damage and dysfunction. Tripterygium glycosides (TG) are known for their strong immunosuppressive and anti-inflammatory effects and are commonly used alongside traditional immunosuppressive agents. However, evidence-based support for the combined use of these treatments in immune-mediated kidney diseases remains insufficient and requires further validation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Purpose<\/jats:title><jats:p>The aim of this study is to evaluate the efficacy and safety of TG combined with immunosuppressive agents in the treatment of immune-mediated kidney diseases.<\/jats:p><\/jats:sec><jats:sec><jats:title>Study design<\/jats:title><jats:p>Systematic Review and Meta-Analysis of Randomized Controlled Trials (RCTs).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We searched nine electronic databases for articles from 1 January 2014 to 1 June 2025. We included the RCTs comparing TG combined with immunosuppressive agents versus immunosuppressive agents alone. Meta-analysis was performed according to the Cochrane Handbook.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Thirty-six RCTs were included, involving 3,455 patients with various conditions such as membranous nephropathy (MN), IgA nephropathy (IgAN), primary nephrotic syndrome (PNS) and others. The combined use of TG and immunosuppressive agents differs from the use of immunosuppressive agents alone in terms of clinical efficacy (RR = 1.26; 95%CI: 1.22\u20131.30), improvement in serum creatinine (Cr) (SMD = \u22120.86; 95%CI: \u22121.11 to \u22120.61), blood urea nitrogen (BUN) (SMD = \u22120.68; 95%CI: \u22121.05 to \u22120.31), 24-h urinary total protein (24h-UTP) (SMD = \u22120.93; 95%CI: \u22121.13 to \u22120.74), and serum albumin (ALB) (SMD = 1.30; 95%CI: 1.08\u20131.52). However, there is no statistically significant difference in the improvement of total cholesterol (TC) (SMD = \u22120.62; 95%CI: \u22121.39 to 0.16). In terms of overall safety, the combination therapy shows a statistically significant difference compared to the use of immunosuppressive agents alone (RR = 0.72; 95%CI: 0.58\u20130.90), but no differences were observed in gastrointestinal issues, liver damage, leukopenia, and infections. Additionally, our analysis found that the combination therapy has a significant advantage over the use of immunosuppressive agents alone in reducing the recurrence rate (RR = 0.21; 95%CI: 0.10\u20130.44). In terms of mechanisms, the final results indicate that there are differences in interleukin-6 (IL-6) and C-reactive protein (CRP) levels between the two groups, while no differences were observed in interleukin-1 (IL-1) and tumor necrosis factor (TNF-\u03b1). However, treatment course, TG dosage, and sample size are important factors influencing the results.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our study suggests that the combination of TG with immunosuppressive agents offers more pronounced efficacy in treating immune mediated kidney diseases, without increasing the incidence of adverse reactions. However, our findings may be limited by the quality of the existing studies. High-quality RCTs are needed to provide more accurate evidence.<\/jats:p><\/jats:sec><jats:sec><jats:title>Systematic Review Registration<\/jats:title><jats:p><jats:ext-link>https:\/\/www.crd.york.ac.uk\/PROSPERO\/view\/CRD42023473530<\/jats:ext-link>.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fphar.2025.1525482","type":"journal-article","created":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T05:23:59Z","timestamp":1752211439000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy of Tripterygium glycosides in immune-mediated kidney diseases as a immunomodulation drug in combination with conventional immunosuppressive agents: a systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.3389","volume":"16","author":[{"given":"Yaotan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyi","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengqi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shijia","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoxian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijuan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nrneph.2015.206","article-title":"Hurdles to the introduction of new therapies for immune-mediated kidney diseases","volume":"12","author":"Anders","year":"2016","journal-title":"Nat. Rev. Nephrol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/s41577-022-00816-y","article-title":"Glomerulonephritis: immunopathogenesis and immunotherapy","volume":"23","author":"Anders","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/s41581-021-00413-7","article-title":"Targeting immune cell metabolism in kidney diseases","volume":"17","author":"Basso","year":"2021","journal-title":"Nat. Rev. Nephrol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.phytochem.2006.11.029","article-title":"Medicinal chemistry and pharmacology of genus Tripterygium (celastraceae)","volume":"68","author":"Brinker","year":"2007","journal-title":"Phytochemistry"},{"key":"B5","doi-asserted-by":"publisher","first-page":"5359635","DOI":"10.1155\/2019\/5359635","article-title":"Inflammation and kidney injury in diabetic African American men","volume":"2019","author":"Cao","year":"2019","journal-title":"J. diabetes Res."},{"key":"B6","first-page":"120","article-title":"Clinical observation of Tripterygium glycosides combined with prednisone in the treatment of adult Henoch-Sch\u00f6nlein purpura nephritis","volume":"11","author":"Chen","year":"2015","journal-title":"Asia Pac. Tradit. Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"Cd008568","DOI":"10.1002\/14651858.CD008568.pub2","article-title":"Tripterygium wilfordii hook F (a traditional Chinese medicine) for primary nephrotic syndrome","author":"Chen","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1207385","DOI":"10.3389\/fphar.2023.1207385","article-title":"Tripterygium glycosides for safely controlling disease activity in systemic lupus erythematosus: a systematic review with meta-analysis and trial sequential analysis","volume":"14","author":"Chen","year":"2023","journal-title":"Front. Pharmacol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"439","DOI":"10.19381\/j.issn.1001-7585.2022.03.032","article-title":"Therapeutic effect of low-dose tacrolimus combined with Tripterygium glycosides on adult idiopathic membranous nephropathy","volume":"35","author":"Chen","year":"2022","journal-title":"Med. Theory Pract."},{"key":"B10","first-page":"763","article-title":"Effect of glycosides tablets on the patients with primary nephrotic syndrome and its influence on inflammatory factors","volume":"29","author":"Chen","year":"2018","journal-title":"Hainan Med. J."},{"key":"B11","first-page":"481","article-title":"Curative effect of Tripterygium glycosides combined with low-dose tacrolimus and glucocorticoids on idiopathic membranous nephropathy and its effect on thromboelastography","volume":"29","author":"Cui","year":"2020","journal-title":"J. Mod. Integr. Chin. West. Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"S637","DOI":"10.1067\/mai.2003.126","article-title":"18. Immune-mediated renal disease","volume":"111","author":"Cunard","year":"2003","journal-title":"J. Allergy Clin. Immunol."},{"key":"B13","first-page":"3051","article-title":"Influence and clinical efficacy of Tripterygium glycosides combined with glucocorticoid on regulatory T cells of patients with nephritic syndrome","volume":"30","author":"Deng","year":"2014","journal-title":"Mod. Med. Health"},{"key":"B14","first-page":"427","article-title":"Clinical study of Tripterygium glycosides combined with leflunomide in the treatment of lupus nephritis","volume":"19","author":"Ding","year":"2019","journal-title":"Chin. J. Pharm. Clin."},{"key":"B15","first-page":"958","article-title":"Tripterginum wilfordii polyglycoside combined with glucocorticoid treatment of refractory nephrotic syndrome","volume":"32","author":"Fan","year":"2014","journal-title":"Chin. J. Traditional Chin. Med. Pharm."},{"key":"B16","first-page":"159","article-title":"Clinical effect of Tripterygium wilfordii polyglycosides combined with low-dose prednisone in the treatment of senile primary nephrotic syndrome","volume":"19","author":"Fang","year":"2021","journal-title":"Chin. Foreign Med. Res."},{"key":"B17","first-page":"80","article-title":"Effect of Tripterygium glycosides combined with mycophenolate mofetil on renal functions and recurrence rate in patients with nephrotic syndromes","volume":"16","author":"Gao","year":"2019","journal-title":"Chin. J. Ration. Drug Use Explor."},{"key":"B18","doi-asserted-by":"publisher","first-page":"139","DOI":"10.16662\/j.cnki.1674-0742.2017.12.139","article-title":"Combined with Tripterygium glycosides of mycophenolate mofetil on refractory nephrotic syndrome patients with renal function","volume":"36","author":"Guo","year":"2017","journal-title":"Chin. Foreign Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"B20","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1515\/med-2016-0099","article-title":"Clinical efficacy and safety of tripterygium glycosides in treatment of stage IV diabetic nephropathy: a meta-analysis","volume":"11","author":"Hong","year":"2016","journal-title":"Open Med. Wars. Pol."},{"key":"B21","first-page":"137","article-title":"Effects of Tripterygium wilfordii polyglycoside tablets on urinary protein, inflammatory factors and immune function in patients with refractory nephrotic syndrome","volume":"28","author":"Jiao","year":"2020","journal-title":"Clin. Res. Cardiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1053\/j.ajkd.2021.07.019","article-title":"Advances in understanding of pathogenesis and treatment of immune-mediated kidney disease: a review","volume":"79","author":"Kant","year":"2022","journal-title":"Am. J. Kidney Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s41572-020-0196-7","article-title":"Podocytopathies","volume":"6","author":"Kopp","year":"2020","journal-title":"Nat. Rev. Dis. Prim."},{"key":"B24","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1080\/1744666X.2022.2045952","article-title":"Interleukin 6 in diabetes, chronic kidney disease, and cardiovascular disease: mechanisms and therapeutic perspectives","volume":"18","author":"Kreiner","year":"2022","journal-title":"Expert Rev. Clin. Immunol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1136\/ard-2022-222495","article-title":"Novel aspects in the pathophysiology and diagnosis of glomerular diseases","volume":"82","author":"Kronbichler","year":"2023","journal-title":"Ann. Rheum. Dis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"28","DOI":"10.16458\/j.cnki.1007-0893.2019.13.013","article-title":"Efficacy of Tripterygium glycosides tablets combined with glucocorticoids in the treatment of nephrotic syndrome","volume":"29","author":"Lai","year":"2019","journal-title":"Shenzhen J. Integr. Traditional Chin. West. Med."},{"key":"B27","first-page":"1","article-title":"Effects of Tripterygium glycosides combined with tarcrolimus on renal function, thromboelastogram, C5-9 and IG-4 in patients with idiopathic membranous nephropathy","volume":"19","author":"Li","year":"","journal-title":"Int. J. Transplant. Blood Purif."},{"key":"B28","first-page":"155","article-title":"Effect of Tripterygium wilfordii polyglycoside combined with leflunomide on lupus nephritis","volume":"13","author":"Li","year":"2022","journal-title":"Chin. Health Stand. Manag."},{"key":"B29","doi-asserted-by":"publisher","first-page":"103257","DOI":"10.1016\/j.autrev.2022.103257","article-title":"Research advances on targeted-Treg therapies on immune-mediated kidney diseases","volume":"22","author":"Li","year":"2023","journal-title":"Autoimmun. Rev."},{"key":"B30","doi-asserted-by":"publisher","first-page":"656621","DOI":"10.3389\/fendo.2021.656621","article-title":"Efficacy and safety of Tripterygium glycoside in the treatment of diabetic nephropathy: a systematic review and meta-analysis based on the duration of medication","volume":"12","author":"Li","year":"","journal-title":"Front. Endocrinol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"608703","DOI":"10.3389\/fphar.2020.608703","article-title":"Clinical practice guideline for Tripterygium glycosides\/Tripterygium wilfordii tablets in the treatment of rheumatoid arthritis","volume":"11","author":"Lin","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B32","first-page":"138","article-title":"Effects of Tripterygium wilfordii tablets combined with glucocorticoids on renal function and serum inflammatory factors in patients with nephrotic syndrome","volume":"14","author":"Liu","year":"2017","journal-title":"J. Hunan Normal Univ. Med. Sci."},{"key":"B33","first-page":"144","article-title":"Efficacy of Tripterygium wilfordii multi glucoside combined with hormone and ARB drugs in the treatment of lupus nephritis","volume":"25","author":"Liu","year":"2018","journal-title":"Chin. J. Contemp. Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"939488","DOI":"10.3389\/fphar.2022.939488","article-title":"Clinical efficacy, safety, and cost of nine Chinese patent medicines combined with ACEI\/ARB in the treatment of early diabetic kidney disease: a network meta-analysis","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"104190","DOI":"10.1016\/j.fitote.2019.104190","article-title":"The genus Tripterygium: a phytochemistry and pharmacological review","volume":"137","author":"Lv","year":"2019","journal-title":"Fitoterapia"},{"key":"B36","doi-asserted-by":"publisher","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"B37","first-page":"1993","article-title":"Effect of Tripterygium glycoside tablets combined with low-dose prednisone on patients with pns and the inflammatory factors","volume":"17","author":"Ni","year":"2022","journal-title":"World J. Integr. Traditional West. Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"889","DOI":"10.13935\/j.cnki.sjzx.221016","article-title":"Clinical efficacy analysis of Tripterygium glycosides combined with mycophenolate mofetil in the treatment of nephrotic syndrome","volume":"29","author":"Ni","year":"2017","journal-title":"Mod. Pract. Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"B40","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.autrev.2012.11.012","article-title":"Standard immunosuppressive therapy of immune-mediated glomerular diseases","volume":"12","author":"Pani","year":"2013","journal-title":"Autoimmun. Rev."},{"key":"B41","doi-asserted-by":"publisher","first-page":"135","DOI":"10.14164\/j.cnki.cn11-5581\/r.2015.09.095","article-title":"Clinical observation on the treatment of refractory nephrotic syndrome with Tripterygium glycosides combined with glucocorticoids","volume":"9","author":"Piao","year":"2015","journal-title":"Chin. Mod. Drug Appl."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.13748\/j.cnki.issn1007-7693.2021.09.014","article-title":"Clincal effects of Tripterygium glycosides combined with prednisone on IgA nephropathy and its effect on urinary Smad2 and TGF-\u03b21","volume":"38","author":"Shen","year":"2021","journal-title":"Chin. J. Mod. Appl. Pharm."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.2147\/DDDT.S367624","article-title":"Quality of evidence supporting the role of Tripterygium glycosides for the treatment of diabetic kidney disease: an overview of systematic reviews and meta-analyses","volume":"16","author":"Shi","year":"2022","journal-title":"Drug Des. devel. Ther."},{"key":"B44","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1631\/jzus.B1900607","article-title":"Use of Tripterygium wilfordii hook F for immune-mediated inflammatory diseases: progress and future prospects","volume":"21","author":"Song","year":"2020","journal-title":"J. Zhejiang Univ. Sci. B"},{"key":"B45","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/s41581-022-00621-9","article-title":"Targeting innate immunity-driven inflammation in CKD and cardiovascular disease","volume":"18","author":"Speer","year":"2022","journal-title":"Nat. Rev. Nephrol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"754","DOI":"10.3389\/fimmu.2018.00754","article-title":"Role of C-Reactive protein at sites of inflammation and infection","volume":"9","author":"Sproston","year":"2018","journal-title":"Front. Immunol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"B48","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nrneph.2017.34","article-title":"T cells and autoimmune kidney disease","volume":"13","author":"Su\u00e1rez-Fueyo","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/cei.13119","article-title":"The role of the immune system in kidney disease","volume":"192","author":"Tecklenborg","year":"2018","journal-title":"Clin. Exp. Immunol."},{"key":"B50","first-page":"47","article-title":"Effect of glycosides on serum indexes in elderly patients with primary nephrotic syndrome","volume":"21","author":"Tian","year":"2017","journal-title":"Pract. Clin. Med. J."},{"key":"B51","first-page":"1073","article-title":"Effects of cyclophosphamide combined with Tripterygium wilfordii preparation on serum chemokine ligand 16,RF,MMP-9 and TIMP-1 in patients with lupus nephritis and rheumatism","volume":"20","author":"Wang","year":"2021","journal-title":"J. Clin. Exp. Med."},{"key":"B52","first-page":"129","article-title":"Analysis of the efficacy of Tripterygium glycosides combined with glucocorticoids in the treatment of refractory nephrotic syndrome","volume":"12","author":"Wang","year":"2014","journal-title":"Contemp. Med. Rev."},{"key":"B53","first-page":"1485","article-title":"Observation on the efficacy of Tripterygium glycosides combined with mycophenolate mofetil in the treatment of refractory nephrotic syndrome","volume":"31","author":"Wang","year":"","journal-title":"Aerosp. Med. J."},{"key":"B54","first-page":"57","article-title":"Clinical observation of Tripterygium glycosides combined with mycophenolate mofetil in the treatment of elderly patients with IgA nephropathy: a study of 30 cases","volume":"23","author":"Wang","year":"2014","journal-title":"Chin. J. Ethnomedicine Ethnopharmacol."},{"key":"B55","first-page":"63","article-title":"Observation on the curative effect of Tripterygium wilfordii polyglycoside tablets combined with low dose of glucocorticoid in the treatment of idiopathic membranous nephropathy","volume":"36","author":"Wang","year":"","journal-title":"Chin. Community Physicians"},{"key":"B56","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.lfs.2017.01.004","article-title":"Treatment of rheumatoid arthritis with combination of methotrexate and Tripterygium wilfordii: a meta-analysis","volume":"171","author":"Wang","year":"2017","journal-title":"Life Sci."},{"key":"B57","doi-asserted-by":"publisher","first-page":"136","DOI":"10.14163\/j.cnki.11-5547\/r.2016.24.101","article-title":"Analysis of the therapeutic effects of dexamethasone combined with Tripterygium glycosides in the treatment of refractory nephrotic syndrome","volume":"11","author":"Wang","year":"2016","journal-title":"Chin. Pract. Med."},{"key":"B58","doi-asserted-by":"publisher","first-page":"130","DOI":"10.14163\/j.cnki.11-5547\/r.2022.19.037","article-title":"Clinical efficacy of Tripterygium glycosides in the treatment of steroid resistant nephrotic syndrome","volume":"17","author":"Wen","year":"2022","journal-title":"Chin. J. Pract. Med."},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20202391","article-title":"Efficacy of Tripterygium glycosides combined with ARB on diabetic nephropathy: a meta-analysis","volume":"40","author":"Wu","year":"2020","journal-title":"Biosci. Rep."},{"key":"B60","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.clinthera.2021.12.006","article-title":"Therapeutic effect and safety of Tripterygium glycosides combined with Western medicine on type 2 diabetic kidney disease: a meta-analysis","volume":"44","author":"Xie","year":"2022","journal-title":"Clin. Ther."},{"key":"B61","doi-asserted-by":"publisher","first-page":"e28134","DOI":"10.1016\/j.heliyon.2024.e28134","article-title":"Cutaneous leukocytoklastic vasculitis in a patient with ankylosing spondylitis: a case report","volume":"10","author":"Xing","year":"2024","journal-title":"Heliyon"},{"key":"B62","first-page":"100","article-title":"Clinical effect of Tripterygium wilfordii polyglycoside tablets combined with prednisone in the treatment of nephrotic syndrome","volume":"26","author":"Xiong","year":"2019","journal-title":"Chin. J. Contemp. Med."},{"key":"B63","first-page":"195","article-title":"Effect of Tripterygium wilfordii polyglycoside combined with low-dose glucocorticoid in treatment of primary glomerulonephritis and its influence on level of SCr and BUN","volume":"24","author":"Yan","year":"2023","journal-title":"Clin. Res. Cardiol."},{"key":"B64","first-page":"194","article-title":"Analysis of the efficacy of Tripterygium glycosides combined with prednisone in the treatment of iga nephropathy with renal function decline","volume":"16","author":"Zhang","year":"2022","journal-title":"Chin. Mod. Drug Appl."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1111\/iju.14665","article-title":"Effect and safety evaluation of tacrolimus and Tripterygium glycosides combined therapy in treatment of Henoch-Sch\u00f6nlein purpura nephritis","volume":"28","author":"Zhang","year":"","journal-title":"Int. J. Urol."},{"key":"B66","first-page":"49","article-title":"Long-term efficacy of Tripterygium wilfordii polyglycosides combined with immunosuppressive agents in the treatment of refractory nephrotic syndrome and its influence on oxidative stress indexes","volume":"7","author":"Zhang","year":"2022","journal-title":"Clin. Med. Res. Pract."},{"key":"B67","doi-asserted-by":"publisher","first-page":"746","DOI":"10.3390\/biom11050746","article-title":"Beneficial modulation of lipid mediator biosynthesis in innate immune cells by antirheumatic Tripterygium wilfordii glycosides","volume":"11","author":"Zhang","year":"","journal-title":"Biomolecules"},{"key":"B68","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.kint.2023.01.018","article-title":"Glucocorticoids for IgA nephropathy-pro","volume":"103","author":"Zhang","year":"2023","journal-title":"Kidney Int."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.13935\/j.cnki.sjzx.150828","article-title":"Clinical efficacy of Tripterygium glycosides tablet combined with glucocorticoid therapy in patients with nephrotic syndrome and analysis on serum inflammatory factors","volume":"10","author":"Zhang","year":"2015","journal-title":"World J. Integr. Traditional West. Med."},{"key":"B70","first-page":"1592","article-title":"Clinical efficacy of Tripterygium glycosides combined with immunosuppressive agents in the treatment of nephrotic syndrome","volume":"39","author":"Zhao","year":"2018","journal-title":"Shaanxi J. Traditional Chin. Med."},{"key":"B71","doi-asserted-by":"publisher","first-page":"67","DOI":"10.13638\/j.issn.1671-4040.2021.22.033","article-title":"Clinical observation of Tripterygium glycosides as adjuvant therapy for elderly patients with refractory nephrotic syndrome","volume":"21","author":"Zheng","year":"2021","journal-title":"Pract. J. Clin. Med. Traditional Chin. West. Med."},{"key":"B72","first-page":"62","article-title":"Observation on the therapeutic efficacy of Tripterygium glycosides combined with glucocorticoids in the treatment of refractory nephrotic syndrome","volume":"36","author":"Zhou","year":"2016","journal-title":"J. Hunan Univ. Chin. Med."},{"key":"B73","doi-asserted-by":"publisher","first-page":"671","DOI":"10.19852\/j.cnki.jtcm.2022.05.001","article-title":"Effectiveness and safety of Tripterygium glycosides tablet for lupus nephritis: a systematic review and meta-analysis","volume":"42","author":"Zhou","year":"2022","journal-title":"J. Tradit. Chin. Med."},{"key":"B74","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1053\/j.ajkd.2013.02.374","article-title":"Tripterygium preparations for the treatment of CKD: a systematic review and meta-analysis","volume":"62","author":"Zhu","year":"2013","journal-title":"Am. J. Kidney Dis."},{"key":"B75","doi-asserted-by":"publisher","first-page":"i157","DOI":"10.1136\/bmj.i157","article-title":"PRISMA harms checklist: improving harms reporting in systematic reviews","volume":"352","author":"Zorzela","year":"2016","journal-title":"BMJ"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1525482\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T05:24:09Z","timestamp":1752211449000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1525482\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,11]]},"references-count":75,"alternative-id":["10.3389\/fphar.2025.1525482"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1525482","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,11]]},"article-number":"1525482"}}